Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$4,156,635
-$30,123 QoQ
Shares Held
8,368
-10.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#514
of 1,735 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cumberland Partners Ltd holds $7,290,948 across 2 Biotechnology names. VRTX ranks #1 (57.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
8,368 | $4,156,635 | |
| 2 | RPRX |
Royalty Pharma plc
|
55,900 | $3,134,313 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,156,635 | 8,368 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $4,186,758 | 9,376 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,355,429 | 9,607 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $3,816,139 | 9,744 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $20,732,963 | 46,570 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $22,663,880 | 46,747 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $19,058,179 | 47,326 | Shares | Defined | 2025-02-03 | |
| 2024-09-30 | $20,091,455 | 43,200 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $13,433,046 | 28,659 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $12,284,059 | 29,387 | Shares | Defined | 2024-05-09 | |
| 2020-12-31 | $27,179 | 115 | Shares | Defined | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||